• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • Arimidex
    • Crestor
    • Nexium
    • Seroquel
    • Symbicort
    • All Drug Products
  • Diseases & Conditions
    • Acid Reflux (Heart Burn)
    • High Cholesterol
    • Asthma
    • Breast Cancer
    • Bipolar Disorder
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Cardiovascular

The following trials provide information to treat various types of cardiovascular diseases, both for ongoing and completed clinical trials.  For more information on this therapy area please click here.

There are a number of ways to help you find trial information.  By using these filters you can find (i) recruiting status, (ii) therapy area, (iii) product and/or (iv) phase of drug development.  You can use one or all filters to identify your specific needs.

When a trial completes the results are reported here no later than one year after completion – this is why you may sometimes find that a Report is unavailable when you are searching through ‘closed’ trials.

  • Expand All
  • Collapse All
  • Pages
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • collapse Long-term follow-up of antithrombotic management patterns in Acute Coronary Syndrome patients
  • collapse Centralized pan-South African Survey on the Undertreatment of Hypercholesterolaemia
  • collapse Osservatorio Regionale sulla Sindrome metabolicA
  • collapse Regional Observation of the Metabolic Syndrome
  • collapse Centralized Gulf States Survey on the Undertreatment of Hypercholesterolemia
  • collapse PAC Prevention study
  • collapse Quality of Life and Treatment Satisfaction of People with Type 2 Diabetes: A European Survey
  • collapse Dyslipaemia, atherosclerosis risk and increased hsCRP and inflammatory and oxidative status in the Spanish population
  • collapse CARE - quality development in cardiovascular disease in general practice
  • collapse Efficiency of rosuvastatin versus the fixed combination of Ezetimibe/Simbastatin to reduce the cholesterol levels in outpatients in a realistic enviroment. A Retrospective Study
  • Pages
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • Expand All
  • Collapse All

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2010